CDH1 Gene Gastric Cancer Hereditary Diffuse NGS Genetic DNA Test
Introduction
The CDH1 Gene Gastric Cancer Hereditary Diffuse NGS Genetic DNA Test is a pivotal examination that helps in identifying hereditary predispositions to gastric cancer. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the CDH1 gene, which is associated with hereditary diffuse gastric cancer (HDGC). Understanding your genetic risk can guide preventive measures and treatment options, making this test an essential tool for individuals with a family history of gastric cancer.
What the Test Measures
This test detects mutations in the CDH1 gene that may increase the risk of developing gastric cancer. By identifying these genetic changes, healthcare providers can assess the likelihood of cancer development and recommend appropriate surveillance and preventive strategies.
Who Should Consider This Test
Individuals who have:
- A family history of gastric cancer, particularly at a young age.
- Known mutations in the CDH1 gene in family members.
- Symptoms such as unexplained weight loss, persistent stomach pain, or nausea.
This test is particularly recommended for those with risk factors associated with hereditary diffuse gastric cancer.
Benefits of Taking the Test
- Early detection of genetic predispositions to gastric cancer.
- Informed decision-making regarding surveillance and preventive measures.
- Access to tailored treatment options based on genetic findings.
- Peace of mind for individuals and families regarding their health risks.
Understanding Your Results
Once the test is completed, results will indicate whether or not a mutation in the CDH1 gene is present. A positive result suggests a higher risk of developing gastric cancer, prompting further discussions with your healthcare provider regarding surveillance options and preventive strategies. A negative result can provide reassurance, although it does not eliminate the risk entirely.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CDH1 Gene Gastric Cancer Hereditary Diffuse NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a genetic counseling session is recommended to draw a pedigree chart of family members affected by CDH1 gene gastric cancer.
Book Your Test Today!
We have branches across Kenya and offer a reliable home sample collection service. Don’t wait to learn more about your genetic health. Book the CDH1 Gene Gastric Cancer Hereditary Diffuse NGS Genetic DNA Test now or contact us at +254711564616 for more information!
